WO2011156587A3 - Methods and systems for anticoagulation risk-benefit evaluations - Google Patents

Methods and systems for anticoagulation risk-benefit evaluations Download PDF

Info

Publication number
WO2011156587A3
WO2011156587A3 PCT/US2011/039788 US2011039788W WO2011156587A3 WO 2011156587 A3 WO2011156587 A3 WO 2011156587A3 US 2011039788 W US2011039788 W US 2011039788W WO 2011156587 A3 WO2011156587 A3 WO 2011156587A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
benefit
treatment
anticoagulation
risk
Prior art date
Application number
PCT/US2011/039788
Other languages
French (fr)
Other versions
WO2011156587A2 (en
Inventor
Julian Casciano
Eben S. Fox
Original Assignee
Daiichi Sankyo, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo, Inc. filed Critical Daiichi Sankyo, Inc.
Publication of WO2011156587A2 publication Critical patent/WO2011156587A2/en
Publication of WO2011156587A3 publication Critical patent/WO2011156587A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Abstract

Methods for identifying an optimal treatment option from a plurality of treatment options, wherein said optimal treatment option provides the largest net benefit (i.e., differential between benefits and risks) for a patient. The methods may compare the benefit of reduced ischemic or stroke events to the bleeding risks associated with anticoagulant treatment before recommending and/or selecting a treatment option that provides the largest net benefit for administration to the patient. Specifically, the methods may evaluate the impact of a particular treatment recommendation by weighing the benefit of an anticoagulant treatment with bleed risks.
PCT/US2011/039788 2010-06-09 2011-06-09 Methods and systems for anticoagulation risk-benefit evaluations WO2011156587A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35319610P 2010-06-09 2010-06-09
US61/353,196 2010-06-09

Publications (2)

Publication Number Publication Date
WO2011156587A2 WO2011156587A2 (en) 2011-12-15
WO2011156587A3 true WO2011156587A3 (en) 2014-03-27

Family

ID=45098667

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/039788 WO2011156587A2 (en) 2010-06-09 2011-06-09 Methods and systems for anticoagulation risk-benefit evaluations

Country Status (1)

Country Link
WO (1) WO2011156587A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130054264A1 (en) * 2011-03-04 2013-02-28 Sterling Point Research, Llc Systems and methods for optimizing medical care through data monitoring and feedback treatment
US11676730B2 (en) 2011-12-16 2023-06-13 Etiometry Inc. System and methods for transitioning patient care from signal based monitoring to risk based monitoring
CN109740255B (en) * 2019-01-02 2021-02-09 北京交通大学 Life prediction method based on time-varying Markov process
CN112328801B (en) * 2020-09-28 2022-06-14 西南电子技术研究所（中国电子科技集团公司第十研究所） Method for predicting group events by event knowledge graph

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050130230A1 (en) * 2003-09-23 2005-06-16 Antoni Davalos Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20070038475A1 (en) * 2005-08-12 2007-02-15 Archimedes, Inc. Dynamic healthcare modeling
US20080010024A1 (en) * 2003-09-23 2008-01-10 Prediction Sciences Llp Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
WO2010055023A1 (en) * 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
US20100125052A1 (en) * 2008-11-14 2010-05-20 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050130230A1 (en) * 2003-09-23 2005-06-16 Antoni Davalos Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20080010024A1 (en) * 2003-09-23 2008-01-10 Prediction Sciences Llp Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
US20070038475A1 (en) * 2005-08-12 2007-02-15 Archimedes, Inc. Dynamic healthcare modeling
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
WO2010055023A1 (en) * 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
US20100125052A1 (en) * 2008-11-14 2010-05-20 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents

Also Published As

Publication number Publication date
WO2011156587A2 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
WO2011070554A3 (en) Finger-worn input devices and methods of use
EP3010326A4 (en) Crop input variety selection systems, methods, and apparatus
WO2012015926A3 (en) Devices and methods for filtering blood plasma
WO2013105986A3 (en) Devices, systems and methods for evaluation of hemostasis
ZA201504489B (en) Agricultural input selection systems, methods and apparatus
WO2012161435A3 (en) Social information management method and system adapted thereto
WO2014083435A3 (en) Handling liquid samples
WO2014079916A3 (en) User interaction monitoring
EP2682052A3 (en) Group performance monitoring system and method
WO2014077898A3 (en) System and method for providing operational intellingence for managed devices
EP2680754A4 (en) Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
WO2012109580A3 (en) Method and system for interacting and servicing users by orientation
WO2012158257A3 (en) Typing input systems, methods, and devices
EP3173765B8 (en) Fiber composite tensile sample, procedure to manufacture and method for performing a tensile test.
WO2012162575A3 (en) Non single point of failure member slide
PH12015500741A1 (en) Use of cry1ea in combinations for management of resistant fall armyworm insects
TWI560991B (en) Harvester and matrix, matrix system, module, tire and foot-ware comprising the same
WO2011137764A3 (en) Method and system for implementing augmented reality applications
WO2012129299A3 (en) Medical instruments and methods for fabricating same
TN2013000388A1 (en) Anticoagulant antidotes
BR112015010427A2 (en) compressor with thrust balance and method thereof.
WO2011156587A3 (en) Methods and systems for anticoagulation risk-benefit evaluations
BR112013023462A2 (en) individuals safety screening method, and safety tray.
WO2011163566A3 (en) Methods of treating patients with immune-related diseases
WO2012138611A3 (en) Customizable interfacing agents, systems, and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11793153

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 11793153

Country of ref document: EP

Kind code of ref document: A2